Stockscreener 앱 받기
2.12
1.85%
-0.04
Xbiotech Inc 주식(XBIT)의 최신 뉴스
XBIT Forecast — Price Target — Prediction for 2027 - TradingView
XBiotech, Inc. Actuals & Estimates (SWB:4XB) - TradingView
XBiotech Inc. SEC Filing (Oct 2, 2026) - Stock Titan
$17.3M in severance is part of a former CEO's 2025 compensation at XBiotech (XBIT). - Stock Titan
Xbiotech Stock Price Forecast. Should You Buy XBIT? - StockInvest.us
XBiotech (NASDAQ:XBIT) Shares Cross Below 200-Day Moving AverageTime to Sell? - MarketBeat
XBiotech (XBIT) Slips 4.78% to $2.19, Testing Key Support at $2.08Supply Zone - vinanet.vn
XBiotech (XBIT) Slips 4.78% to $2.19, Testing Key Support at $2.08Sector ETF Flow - careplusvn.com
XBiotech (XBIT) Slips 4.78% to $2.19, Testing Key Support at $2.08Island Reversal - dars.gov.et
XBiotech (XBIT) Slips 4.78% to $2.19, Testing Key Support at $2.08OBV Trend Line - dars.gov.et
XBiotech (NASDAQ:XBIT) Share Price Passes Above 50 Day Moving AverageHere's What Happened - MarketBeat
XBiotech (XBIT) Quarter in Focus: Reported EPS Misses Expectations for This Review; Closing Move - vinanet.vn
XBiotech (XBIT) Move: Advances 0.22% to $2.30 for the Current Session; Current Setup: Price Remains Between $2.18 Support and $2.42 Resistance at the CloseEarly Entry Signals - vinanet.vn
XBiotech (XBIT) Move: Advances 0.22% to $2.30 for the Current Session; Current Setup: Price Remains Between $2.18 Support and $2.42 Resistance at the CloseLinear Regression - dars.gov.et
XBiotech (XBIT) Quarter in Focus: Reported EPS Misses Expectations for This Review; Closing Move: The Market Price Advances 0.65% at the CloseRevenue Growth Outlook - dars.gov.et
XBiotech (XBIT) Quarter in Focus: Reported EPS Misses Expectations for This Review; Closing Move - siam.in
XBiotech (XBIT) Quarter in Focus: Reported EPS Misses Expectations for This Review; Closing Move - dars.gov.et
XBiotech (XBIT) Move: Advances 0.22% to $2.30 for the Current Session; Current Setup: Price Remains Between $2.18 Support and $2.42 Resistance at the CloseMomentum ETF - careplusvn.com
XBiotech (XBIT) Quarter in Focus: Reported EPS Misses Expectations for This Review; Closing Move: The Market Price Advances 0.65% at the CloseProfitability Analysis - dars.gov.et
XBiotech (XBIT) Quarter in Focus: Reported EPS Misses Expectations for This Review; Closing Move: The Market Price Advances 0.65% at the CloseEarnings Call Q&A - www.dars.gov.et
XBiotech (XBIT) Move: Advances 0.22% to $2.30 for the Current Session; Current Setup: Price Remains Between $2.18 Support and $2.42 Resistance at the CloseInitial Balance - dars.gov.et
XBiotech (XBIT) Move: Advances 0.22% to $2.30 for the Current Session; Current Setup: Price Remains Between $2.18 Support and $2.42 Resistance at the CloseBull Flag - dars.gov.et
XBiotech (NASDAQ:XBIT) Issues Quarterly Earnings Results, Misses Estimates By $0.25 EPS - MarketBeat
XBiotech: Q2 Earnings Snapshot - marketscreener.com
XBiotech: Q2 Earnings Snapshot - AOL.com
XBiotech: Q2 Earnings Snapshot - Enidnews.com
XBiotech: Q2 Earnings Snapshot - KTVB
XBiotech (NASDAQ: XBIT) trims R&D spend yet remains loss-making in Q2 2026 - Stock Titan
XBiotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
XBiotech: Q2 Earnings Snapshot - Barchart.com
XBiotech (XBIT) Earnings Date and Reports 2026 $XBIT - MarketBeat
XBiotech: Q2 Earnings Snapshot - Yahoo Finance
XBiotech (XBIT) Edges Higher at $2.28 as Stock Consolidates Between Key Support and ResistanceOverbought Signal Alerts - careplusvn.com
XBiotech (XBIT) Edges Higher at $2.28 as Stock Consolidates Between Key Support and ResistanceRip Sell Trade - dars.gov.et
XBiotech (XBIT) Edges Higher at $2.28 as Stock Consolidates Between Key Support and ResistanceActive ETF Flow - dars.gov.et
XBiotech (XBIT) Edges Higher at $2.28 as Stock Consolidates Between Key Support and ResistanceJelly Roll Trade - dars.gov.et
XBiotech Inc (XBIT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
XBiotech Inc (XBIT) Stock News Today - TradingKey
XBiotech (NASDAQ:XBIT) Share Price Crosses Below 200-Day Moving AverageWhat's Next? - MarketBeat
XBiotech Inc (XBIT) Income Statement - TradingKey
XBiotech Inc (XBIT) Institutional Confidence - TradingKey
XBiotech Inc (XBIT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
XBiotech Inc (XBIT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
XBiotech Inc (XBIT) Balance Sheet - TradingKey
XBIT|XBiotech Inc|Price:2.300|Chg%:+0.030 - TradingKey
XBiotech Inc (XBIT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
XBiotech Inc (XBIT) Cash Flow - TradingKey
XBiotech Inc (XBIT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
XBiotech Inc (XBIT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
XBIT|XBiotech Inc|Price:2.270| - TradingKey
4.22%
자본화:
|
볼륨(24시간):